Business
Fresenius Medical Care delivers 18% earnings growth in 2024 and continues the acceleration momentum into 2025
"Fresenius Medical Care has again delivered against its commitments and we met the top end of our 2024 target to profitably grow our business. We successfully executed against our strategic turnaround and transformation plan, advancing our legacy portfolio optimization and realizing significant FME25 savings ahead of plan. The momentum we have created enables us to further raise our FME25 savings target from EUR 650 million to EUR 750 million", said Helen Giza, Chief Executive Officer of Freseni
About this update from Fresenius Medical Care Ag
[{"type":"list","items":[{"val":[{"type":"text","content":"Organic revenue growth1 of 4% driven by Care Enablement and Care Delivery","length":78,"tagName":"p"}]},{"val":[{"type":"text","content":"Underlying U.S. same market treatment growth further accelerated in Q4 and turned positive for the full year","length":108,"tagName":"p"}]},{"val":[{"type":"text","content":"Accumulated savings of the FME25 program already reached EUR 567 million and 2025 target raised to EUR 750 million","length":119,"tagName":"p"}]},{"val":[{"type":"text","content":"With 18% operating income2 growth top end of the 2024 outlook range reached","length":75,"tagName":"p"}]},{"val":[{"type":"text","content":"Reported operating income grew by 2%, reported net income3 by +8%","length":65,"tagName":"p"}]},{"val":[{"type":"text","content":"Net financial leverage ratio reduced from 3.2x to 2.9x and dividend is planned to be raised by 21%","length":98,"tagName":"p"}]},{"val":[{"type":"text","content":"High teens to high twenties percent earnings growth in 2025, translating into an 11 to 12% margin","length":97,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":640,"olType":false},{"type":"text","content":"BAD HOMBURG, Germany, Feb. 25, 2025 /PRNewswire/ -- "Fresenius Medical Care has again delivered against its commitments and we met the top end of our 2024 target to profitably grow our business. We successfully executed against our strategic turnaround and transformation plan, advancing our legacy portfolio optimization and realizing significant FME25 savings ahead of plan. The momentum we have created enables us to further raise our FME25 savings target from EUR 650 million to EUR 750 million", said Helen Giza, Chief Executive Officer of Fresenius Medical Care AG. "Our continued focus on improving operational performance resulted in meaningful progress in the operating income margin towards our 2025 margin targets. Over the course of the past financial year, both business segments contributed to the positive development." Giza added: "In Care Delivery, a key milestone was underlying U.S. same market treatment growth remaining positive for the second consecutive quarter and turning positive for the full year. Care Enablement recorded accelerated volume growth alongside continued positive pricing momentum. The strong operating income imp...